919 / 1266
PAge72
1/25/2016 |
Author
Division
a
Olaf Witt
SIOP LGG 201X
Warum molekulare Biomarker?
Meta-analysis SIOP LGG pre-clinical working group:
⇒
BRAF KIAA fusions type independent prognostics factor
(multivariate analysis: age, location, histology, extend of
resection)
Why molecular biomarkers II ?